Olivier B Engler
Overview
Explore the profile of Olivier B Engler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Siegrist D, Jonsdottir H, Bouveret M, Boda B, Constant S, Engler O
Pharmaceutics
. 2024 Oct;
16(10).
PMID: 39458594
The emergence, global spread, and persistence of SARS-CoV-2 resulted in an unprecedented need for effective antiviral drugs. Throughout the pandemic, various drug development and treatment strategies were adopted, including repurposing...
2.
Jandrasits D, Zust R, Siegrist D, Engler O, Weber B, Schmidt K, et al.
Heliyon
. 2024 Jun;
10(10):e31490.
PMID: 38826712
Due to the discontinuation of routine smallpox vaccination after its eradication in 1980, a large part of the human population remains naïve against smallpox and other members of the orthopoxvirus...
3.
Jonsdottir H, Zysset D, Lenz N, Siegrist D, Ruedin Y, Ryter S, et al.
Sci Rep
. 2023 Sep;
13(1):15718.
PMID: 37735604
Proper disinfection and inactivation of highly pathogenic viruses is an essential component of public health and prevention. Depending on environment, surfaces, and type of contaminant, various methods of disinfection must...
4.
Jonsdottir H, Siegrist D, Julien T, Padey B, Bouveret M, Terrier O, et al.
Biomed Pharmacother
. 2022 Jun;
150:113058.
PMID: 35658229
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide pandemic with unprecedented economic and societal impact. Currently, several vaccines are available and multitudes of antiviral treatments have...
5.
Signer J, Jonsdottir H, Albrich W, Strasser M, Zust R, Ryter S, et al.
Virol J
. 2020 Nov;
17(1):172.
PMID: 33168000
The original version of the acknowledgement unfortunately contained a mistake.
6.
Signer J, Jonsdottir H, Albrich W, Strasser M, Zust R, Ryter S, et al.
Virol J
. 2020 Sep;
17(1):136.
PMID: 32907596
Background: Coronaviruses (CoVs) were long thought to only cause mild respiratory and gastrointestinal symptoms in humans but outbreaks of Middle East Respiratory Syndrome (MERS)-CoV, Severe Acute Respiratory Syndrome (SARS)-CoV-1, and...
7.
Wolk B, Gremion C, Ivashkina N, Engler O, Grabscheid B, Bieck E, et al.
J Gen Virol
. 2005 May;
86(Pt 6):1737-1746.
PMID: 15914852
The cellular immune response plays a central role in virus clearance and pathogenesis of liver disease in hepatitis C. The study of hepatitis C virus (HCV)-specific immune responses is limited...
8.
Engler O, Schwendener R, Dai W, Wolk B, Pichler W, Moradpour D, et al.
Vaccine
. 2004 Nov;
23(1):58-68.
PMID: 15519708
Virus specific T cell responses play an important role in resolving acute hepatitis C virus (HCV) infections. Using the HLA-A2.1 transgenic mouse model we investigated the potential of a liposomal...
9.
Engler O, Strasser I, Naisbitt D, Cerny A, Pichler W
Toxicology
. 2004 Mar;
197(1):47-56.
PMID: 15003333
Drugs can interact with T cell receptors (TCR) after binding to peptide-MHC structures. This binding may involve the formation of a stable, covalent bond between a chemically reactive drug and...